The use of fibrin sealant during non-emergency surgery: A systematic review of evidence of benefits and harms

Health Technology Assessment

Volumn 20, Issue 94, 2016, Pages

  Edwards, Steven J ^a   Crawford, Fay ^a   van Velthoven, Michelle Helena ^a   Berardi, Andrea ^a   Osei Assibey, George ^a   Bacelar, Mariana ^a   Salih, Fatima ^a   Wakefield, Victoria ^a  

^a British Medical Journal Technology Assessment Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE;

ADULT; AIR EMBOLISM; BREAST SURGERY; CLINICAL EFFECTIVENESS; COLORECTAL SURGERY; EVIDENCE BASED MEDICINE; FEMALE; GASTROINTESTINAL SURGERY; GYNECOLOGIC SURGERY; HEMATOMA; HUMAN; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MAXILLOFACIAL SURGERY; META ANALYSIS; MORTALITY; NEUROSURGERY; OBSERVATIONAL STUDY; ORAL SURGERY; ORTHOPEDIC SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEROMA; SURGICAL EQUIPMENT; UROLOGIC SURGERY; LENGTH OF STAY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PROCEDURES; QUALITY OF LIFE; STATISTICS AND NUMERICAL DATA; SURGERY; SURGICAL INFECTION;

FIBRIN TISSUE ADHESIVE; HEMATOMA; HUMANS; LENGTH OF STAY; OBSERVATIONAL STUDIES AS TOPIC; OPERATIVE TIME; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; SEROMA; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION;

EID: 85009742550     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta20940     Document Type: Review

References (261)

1. Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol 2003;29: 711-17. http://dx.doi.org/10.1016/S0748-7983(03)00096-9
2. Sözen S, Topuz O, Tükenmez M, Keçeli M. The use of fibrin sealant after total thyroidectomy for benign disease obviates the need for routine drainage. Results of a randomized controlled trial. Hippokratia 2011;15: 247-51.
3. Kim TW, Choi SY, Jang MS, Lee GG, Nam ME, Son YI, et al. Efficacy of fibrin sealant for drainage reduction in total thyroidectomy with bilateral central neck dissection. Otolaryngol Head Neck Surg 2012;147: 654-60. http://dx.doi.org/10.1177/0194599812449315
4. Hsu HK, Hsu WH, Huang MH. Prospective study of using fibrin glue to prevent leak from esophagogastric anastomosis. J Surg Assoc 1992;25: 1248-52.
5. Handmer M. Sticking to the facts: a systematic review of fibrin glue for pilonidal disease. ANZ J Surg 2012;82: 221-4. http://dx.doi.org/10.1111/j.1445-2197.2011.05752.x
6. Cheng Y, Xiong X, Peng S, Wu Hong M, Cheng N. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database Syst Rev 2012;2: CD009621. http://dx.doi.org/10.1002/14651858.cd009621
7. Fingerhut A, Veyrie N, Ata T, Alexakis N, Leandros E. Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg 2009;26: 7-14. http://dx.doi.org/10.1159/000191284
8. Ohwada S, Ogawa T, Tanahashi Y, Nakamura S, Takeyoshi I, Ohya T, et al. Fibrin glue sandwich prevents pancreatic fistula following distal pancreatectomy. World J Surg 1998;22: 494-8. http://dx.doi.org/10.1007/s002689900423
9. Morales-Conde S, Barranco A, Socas M, Alarcón I, Grau M, Casado MA. Systematic review of the use of fibrin sealant in abdominal-wall repair surgery. Hernia 2011;15: 361-9. http://dx.doi.org/10.1007/s10029-011-0809-x
10. Green AL, Arnaud A, Batiller J, Eljamel S, Gauld J, Jones P, et al. A multicentre, prospective, randomized, controlled study to evaluate the use of a fibrin sealant as an adjunct to sutured dural repair. Br J Neurosurg 2015;29: 11-17. http://dx.doi.org/10.3109/02688697.2014.948808
11. Koh MB, Hunt BJ. The management of perioperative bleeding. Blood Rev 2003;17: 179-85. http://dx.doi.org/10.1016/S0268-960X(02)00062-0
12. Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 2011;11: CD005355. http://dx.doi.org/10.1002/14651858. cd005355.pub4
13. Liu J, Cao JG, Wang L, Ma XL. Effect of fibrin sealant on blood loss following total knee arthroplasty: a systematic review and meta-analysis. Int J Surg 2014;12: 95-102. http://dx.doi.org/10.1016/j.ijsu.2013.11.011
14. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999;81: 1580-8. http://dx.doi.org/10.2106/00004623-199911000-00010
15. Petrek JA, Peters MM, Nori S, Knauer C, Kinne DW, Rogatko A. Axillary lymphadenectomy. A prospective, randomized trial of 13 factors influencing drainage, including early or delayed arm mobilization. Arch Surg 1990;125: 378-82. http://dx.doi.org/10.1001/ archsurg.1990.01410150100018
16. Terrell GS, Singer JA. Axillary versus combined axillary and pectoral drainage after modified radical mastectomy. Surg Gynecol Obstet 1992;175: 437-40.
17. Smith MM, Lin MP, Hovsepian RV, Wood D, Nguyen T, Evans GR, et al. Postoperative seroma formation after abdominoplasty with placement of continuous infusion local anesthetic pain pump. Can J Plast Surg 2009;17: 127-9. http://dx.doi.org/10.4172/plastic-surgery.1000624
18. Khaira HS, Lall P, Hunter B, Brown JH. Repair of incisional hernias. J R Coll Surg Edinb 2001;46: 39-43.
19. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138: 8-13. http://dx.doi.org/10.1016/j.surg.2005.05.001
20. Dong Z, Xu J, Wang Z, Petrov MS. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst Rev 2013;6: CD008914. http://dx.doi.org/10.1002/14651858.cd008914.pub2
21. Gurusamy KS, Koti R, Fusai G, Davidson BR. Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev 2010;2: CD008370. http://dx.doi.org/10.1002/14651858.cd008370
22. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 2005;92: 1059-67. http://dx.doi.org/10.1002/bjs.5107
23. Shander A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 2007;142(Suppl. 4): 20-5. http://dx.doi.org/10.1016/j.surg.2007.06.025
24. Hasley PB, Lave JR, Hanusa BH, Arena VC, Ramsey G, Kapoor WN, et al. Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions. Med Care 1995;33: 1145-60. http://dx.doi.org/10.1097/00005650-199511000-00007
25. Hebert PC, Schweitzer I, Calder L, Blajchman M, Giulivi A. Review of the clinical practice literature on allogeneic red blood cell transfusion. CMAJ 1997;156: 9-26.
26. Marietta M, Facchini L, Pedrazzi P, Busani S, Torelli G. Pathophysiology of bleeding in surgery. Transplant Proc 2006;38: 812-14. http://dx.doi.org/10.1016/j.transproceed.2006.01.047
27. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013;17: R76. http://dx.doi.org/10.1186/cc12685
28. Schulick RD, Yoshimura K. Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/ fistulae? J Gastrointest Surg 2009;13: 1184-6. http://dx.doi.org/10.1007/s11605-009-0866-y
29. Wente MN, Shrikhande SV, Müller MW, Diener MK, Seiler CM, Friess H, et al. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 2007;193: 171-83. http://dx.doi.org/10.1016/j.amjsurg.2006.10.010
30. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998;86: 9-15.
31. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a metaanalysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998;158: 610-16. http://dx.doi.org/10.1001/archinte.158.6.610
32. Huët C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999;89: 861-9. http://dx.doi.org/10.1213/00000539-199910000-00009
33. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 1997;85: 1258-67. http://dx.doi.org/10.1213/00000539-199712000-00014
34. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 1998;8: 309-17. http://dx.doi.org/10.1046/j.1365-3148.1998.00171.x
35. Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;1: CD001886. http://dx.doi.org/10.1002/14651858.cd001886.pub3
36. EMA. Fibrinogen-Containing Solutions for Sealant Authorised for Administration by Spray Application. 2012. URL: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/ referrals/Fibrinogen-containing_solutions_for_sealant_authorised_for_administration_by_spray_ application/human_referral_000332.jsp&mid=WC0b01ac05805c516f (accessed 19 May 2015).
37. MHRA. Sprayable Fibrin Sealants (Evicel, Tisseel and Artiss): Updated Guidance. London: MHRA; 2013.
38. Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2003;2: CD004171. http://dx.doi.org/10.1002/14651858.cd004171
39. Food and Drugs Administration. Risk of Life Threatening Air or Gas Embolism with the Use of Spray Devices Employing Pressure Regulator to Administer Fibrin Sealants (Baxter Health Care Corporation). 2009. URL: www.fda.gov/biologicsbloodvaccines/safetyavailability/ucm209778.htm (accessed 19 May 2015).
40. Kjaergard HK, Fairbrother JE. Controlled clinical studies of fibrin sealant in cardiothoracic surgery - a review. Eur J Cardiothorac Surg 1996;10: 727-33. http://dx.doi.org/10.1016/ S1010-7940(96)80332-0
41. Cardillo G, Carleo F, Carbone L, De Massimi AR, Lococo A, Santini PF, et al. Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial. Eur J Cardiothorac Surg 2012;41: 657-62. http://dx.doi.org/10.1093/ ejcts/ezr083
42. Epstein NE. Dural repair with four spinal sealants: focused review of the manufacturers’ inserts and the current literature. Spine J 2010;10: 1065-8. http://dx.doi.org/10.1016/j.spinee.2010.09.017
43. CRD. Systematic Reviews: Centre for Reviews and Dissemination (CRD) Guidance for Undertaking Systematic Reviews in Health Care. York: CRD; 2010. URL: www.york.ac.uk/inst/crd/index_ guidance.htm (accessed 19 May 2015).
44. Higgins JPT, Green S. Cochrane Handbook Version 5.1.0. 2011. URL: http://handbook.cochrane.org/ (accessed 19 May 2015).
45. Crawford F, Edwards S, van Velthoven M, Osei-Assibey G. The Use of Fibrin Sealants During Non-Emergency Surgery: A Systematic Review of the Evidence of Benefits and Harms. CRD, University of York; 2015. URL: www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015020710 (accessed 19 May 2015).
46. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. BMJ 2009;339: b2535. http://dx.doi.org/10.1136/bmj.b2535
47. Zorzela L, Golder S, Liu Y, Pilkington K, Hartling L, Joffe A, et al. Quality of reporting in systematic reviews of adverse events: systematic review. BMJ 2014;348: f7668. http://dx.doi.org/10.1136/ bmj.f7668
48. Loke YK, Price D, Herxheimer A, Cochrane Adverse Effects Methods Group. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol 2007;7: 32. http://dx.doi.org/10.1186/1471-2288-7-32
49. McIntosh HM, Woolacott NF, Bagnall AM. Assessing harmful effects in systematic reviews. BMC Med Res Methodol 2004;4: 19. http://dx.doi.org/10.1186/1471-2288-4-19
50. Higgins JPT, Green S. Intention-to-treat Issues for Dichotomous Data. 2011. URL: http:// handbook.cochrane.org/chapter_16/16_2_2_intention_to_treat_issues_for_dichotomous_data.htm (accessed 19 May 2015).
51. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2014. URL: www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 19 May 2015).
52. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52: 377-84. http://dx.doi.org/10.1136/jech.52.6.377
53. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315: 629-34. http://dx.doi.org/10.1136/bmj.315.7109.629
54. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-48.
55. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-88. http://dx.doi.org/10.1016/0197-2456(86)90046-2
56. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327: 557-60. http://dx.doi.org/10.1136/bmj.327.7414.557
57. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21: 1559-73. http://dx.doi.org/10.1002/sim.1187
58. Royal College of Surgeons. Surgical Specialties. URL: www.rcseng.ac.uk/patients/the-surgical-team/ surgical-specialties (accessed October 2015).
59. Nativ O, Patel B, Shen J, Batiller J, Horn S, Hart JC. Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study. BMC Nephrol 2012;13: 147. http://dx.doi.org/10.1186/1471-2369-13-147
60. Tavilla G, Bruggemans EF, Gielen CL, Brand A, van den Hout WB, Klautz RJ, et al. Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study). Br J Surg 2015;102: 1338-47. http://dx.doi.org/10.1002/bjs.9877
61. Hwang TL, Chen MF. Randomized trial of fibrin tissue glue for low output enterocutaneous fistula. Br J Surg 1996;83: 112. http://dx.doi.org/10.1002/bjs.1800830135
62. Silecchia G, Boru CE, Mouiel J, Rossi M, Anselmino M, Morino M, et al. The use of fibrin sealant to prevent major complications following laparoscopic gastric bypass: results of a multicenter, randomized trial. Surg Endosc 2008;22: 2492-7. http://dx.doi.org/10.1007/s00464-008-9885-0
63. Fernandez Fernandez L, Tejero E, Tieso A. Randomized trial of fibrin glue to seal mechanical oesophagojejunal anastomosis. Br J Surg 1996;83: 40-1. http://dx.doi.org/10.1002/bjs.1800830111
64. Huang O, Lu X, Xu X, Shi Y. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up. Cell Biochem Biophys 2015;71: 1171-80. http://dx.doi.org/10.1007/s12013-014-0326-5
65. Bektas H, Nadalin S, Szabo I, Ploder B, Sharkhawy M, Schmidt J. Hemostatic efficacy of latest-generation fibrin sealant after hepatic resection: a randomized controlled clinical study. Langenbecks Arch Surg 2014;399: 837-47. http://dx.doi.org/10.1007/s00423-014-1227-1
66. de Boer MT, Klaase JM, Verhoef C, van Dam RM, van Gulik TM, Molenaar IQ, et al. Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg 2012;256: 229-34. http://dx.doi.org/10.1097/SLA.0b013e3182602819
67. Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg 2000;135: 1200-4. http://dx.doi.org/10.1001/archsurg.135.10.1200
68. Uetsuji S, Komada Y, Kwon AH, Imamura A, Takai S, Kamiyama Y. Prevention of pleural effusion after hepatectomy using fibrin sealant. Int Surg 1994;79: 135-7.
69. Liu M, Lui WY. The use of fibrin adhesive for hemostasis after liver resection. Zhonghua yi xue za zhi 1993;1: 19-22.
70. Noun R, Elias D, Balladur P, Bismuth H, Parc R, Lasser P, et al. Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology 1996;43: 221-4.
71. Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, et al. Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg 2007;245: 536-42. http://dx.doi.org/10.1097/01.sla.0000245846.37046.57
72. Fischer L, Seiler CM, Broelsch CE, de Hemptinne B, Klempnauer J, Mischinger HJ, et al. Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery 2011;149: 48-55. http://dx.doi.org/10.1016/j.surg.2010.02.008
73. Frilling A, Stavrou GA, Mischinger HJ, De Hemptinne B, Rokkjaer M, Klempnauer J, et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 2005;390: 114-20. http://dx.doi.org/10.1007/s00423-005-0543-x
74. Kakaei F, Seyyed Sadeghi MS, Sanei B, Hashemzadeh S, Habibzadeh A. A randomized clinical trial comparing the effect of different haemostatic agents for haemostasis of the liver after hepatic resection. HPB Surg 2013;2013: 587608. http://dx.doi.org/10.1155/2013/587608
75. Kohno H, Nagasue N, Chang YC, Taniura H, Yamanoi A, Nakamura T. Comparison of topical hemostatic agents in elective hepatic resection: a clinical prospective randomized trial. World J Surg 1992;16: 966-9. http://dx.doi.org/10.1007/BF02067005
76. Moench C, Mihaljevic AL, Hermanutz V, Thasler WE, Suna K, Diener MK, et al. Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop® compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619). Langenbecks Arch Surg 2014;399: 725-33. http://dx.doi.org/10.1007/s00423-014-1203-9
77. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004;139: 1148-54. http://dx.doi.org/10.1001/archsurg.139.11.1148
78. Fu JZ, Li J, Yu ZL. Effect of implanting fibrin sealant with ropivacaine on pain after laparoscopic cholecystectomy. World J Gastroenterol 2009;15: 5851-4. http://dx.doi.org/10.3748/wjg.15.5851
79. Danielsen PL, Agren MS, Jorgensen LN. Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. Ann Surg 2010;251: 825-31. http://dx.doi.org/10.1097/SLA.0b013e3181d3548c
80. Dimo B, Jørgensen T, Kjaergaard J, Luke M, Kvist E, Hjortrup A. Randomized trial of fibrin adhesive for reduction of drained secretion after elective cholecystectomy. Acta Chir Scand 1989;155: 177-8.
81. Carter TI, Fong ZV, Hyslop T, Lavu H, Tan WP, Hardacre J, et al. A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg 2013;17: 102-9. http://dx.doi.org/10.1007/s11605-012-1963-x
82. Suzuki Y, Kuroda Y, Morita A, Fujino Y, Tanioka Y, Kawamura T, et al. Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Arch Surg 1995;130: 952-5. http://dx.doi.org/10.1001/archsurg.1995.01430090038015
83. Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2004;8: 766-72. http://dx.doi.org/10.1016/ j.gassur.2004.06.011
84. Montorsi M, Zerbi A, Bassi C, Capussotti L, Coppola R, Sacchi M, et al. Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial. Ann Surg 2012;256: 853-9. http://dx.doi.org/10.1097/SLA.0b013e318272dec0
85. Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmières F, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg 2003;237: 57-65. http://dx.doi.org/10.1097/00000658-200301000-00009
86. Martin I, Au K. Does fibrin glue sealant decrease the rate of anastomotic leak after a pancreaticoduodenectomy? Results of a prospective randomized trial. HPB 2013;15: 561-6. http://dx.doi.org/10.1111/hpb.12018
87. Oliver JL, Medina IA, Garcıa-Almenta EM, Martin GJ, Sanchez MS, Diaz P. [Use of fibrin based biological adhesives in the prevention of anastomotic leaks in the high risk digestive tract: preliminary results of the multicentre, prospective, randomised, controlled, and simple blind phase IV clinical trial: Protissucol001.] CIR ESP 2012;10: 647-55. http://dx.doi.org/10.1016/ j.ciresp.2012.05.007
88. Musella M, Milone M, Maietta P, Bianco P, Pisapia A, Gaudioso D. Laparoscopic sleeve gastrectomy: efficacy of fibrin sealant in reducing postoperative bleeding. A randomized controlled trial. Updates Surg 2014;66: 197-201. http://dx.doi.org/10.1007/s13304-014-0257-0
89. Pilone V, Di Micco R, Monda A, Villamaina E, Forestieri P. Use of Tachosil® in bariatric surgery: preliminary experience in control of bleeding after sleeve gastrectomy. Minerva Chir 2012;67: 241-8.
90. Sroka G, Milevski D, Shteinberg D, Mady H, Matter I. Minimizing hemorrhagic complications in laparoscopic sleeve gastrectomy - a randomized controlled trial. Obes Surg 2015;25: 1577-83. http://dx.doi.org/10.1007/s11695-015-1580-3
91. Fékété F, Gayet B, Panis Y. [Contribution of fibrin glue to the reinforcement of esophageal anastomoses.] Presse Med 1992;21: 157-9.
92. Bulbuller N, Aslaner A, Oner OZ, Oruc MT, Koc U, Ongen NA, et al. Comparison of four different methods in staple line reinforcement during laparascopic sleeve gastrectomy. Int J Clin Exp Med 2013;6: 985-90.
93. Huang J, Qian L. The study on the efficacy of fibrin glue in preventing post-traumatic focal pancreatitis (PTFP) after radical gastrectomy. J Gastrointest Surg 2014;18: 476-80. http://dx.doi.org/10.1007/s11605-013-2442-8
94. Carlson JW, Kauderer J, Walker JL, Gold MA, O’Malley D, Tuller E, et al. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol 2008;110: 76-82. http://dx.doi.org/10.1016/ j.ygyno.2008.03.005
95. Zhibo X, Miaobo Z. Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation. Aesthet Surg J 2009;29: 32-4. http://dx.doi.org/10.1016/j.asj.2008.10.008
96. Ulusoy AN, Polat C, Alvur M, Kandemir B, Bulut F. Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. Breast J 2003;9: 393-6. http://dx.doi.org/10.1046/j.1524-4741.2003.09506.x
97. Dinsmore RC, Harris JA, Gustafson RJ. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. Am Surg 2000;66: 982-5.
98. Udén P, Aspegren K, Balldin G, Garne JP, Larsson SA. Fibrin adhesive in radical mastectomy. Eur J Surg 1993;159: 263-5.
99. Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg 2004;91: 54-60. http://dx.doi.org/10.1002/bjs.4435
100. Johnson L, Cusick TE, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg 2005;189: 319-23. http://dx.doi.org/10.1016/j.amjsurg.2005.01.004
101. Llewellyn-Bennett R, Greenwood R, Benson JR, English R, Turner J, Rayter Z, et al. Randomized clinical trial on the effect of fibrin sealant on latissimus dorsi donor-site seroma formation after breast reconstruction. Br J Surg 2012;99: 1381-8. http://dx.doi.org/10.1002/bjs.8874
102. Ko E, Han W, Cho J, Lee JW, Kang SY, Jung SY, et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. J Korean Med Sci 2009;24: 92-6. http://dx.doi.org/10.3346/jkms.2009.24.1.92
103. Miri Bonjar MR, Maghsoudi H, Samnia R, Saleh P, Parsafar F. Efficacy of fibrin glue on seroma formation after breast surgery. Int J Breast Cancer 2012;2012: 643132. http://dx.doi.org/10.1155/2012/643132
104. Mustonen PK, Härmä MA, Eskelinen MJ. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg 2004;93: 209-12.
105. Segura-Castillo JL, Estrada-Rivera O, Castro-Cervantes JM, Cortés-Flores AO, Velázquez-Ramírez GA, González-Ojeda A. [Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue.] Cir Cir 2005;73: 345-50.
106. Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg 1997;63: 97-102.
107. Berger A, Tempfer C, Hartmann B, Kornprat P, Rossmann A, Neuwirth G, et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Res Treat 2001;67: 9-14. http://dx.doi.org/10.1023/A: 1010671209279
108. Gilly FN, Francois Y, Sayag-Beaujard AC, Glehen O, Brachet A, Vignal J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res 1998;30: 439-43. http://dx.doi.org/10.1159/000008611
109. Benevento R, Santoriello A, Pellino G, Sciaudone G, Candilio G, De Fatico GS, et al. The effects of low-thrombin fibrin sealant on wound serous drainage, seroma formation and length of postoperative stay in patients undergoing axillary node dissection for breast cancer: a randomized controlled trial. Int J Surg 2014;12: 1210-15. http://dx.doi.org/10.1016/j.ijsu.2014.10.005
110. Cipolla C, Fricano S, Vieni S, Graceffa G, Licari G, Torcivia A, et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. J Surg Oncol 2010;101: 600-3. http://dx.doi.org/10.1002/ jso.21531
111. Moore M, Burak WE Jr, Nelson E, Kearney T, Simmons R, Mayers L, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 2001;192: 591-9. http://dx.doi.org/10.1016/S1072-7515(01)00827-4
112. Vaxman F, Kolbe A, Stricher F, Zund D, Volkmar P, Gros D, et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 1995;27: 346-52. http://dx.doi.org/10.1159/000129419
113. Swan MC, Oliver DW, Cassell OC, Coleman DJ, Williams N, Morritt DG, et al. Randomized controlled trial of fibrin sealant to reduce postoperative drainage following elective lymph node dissection. Br J Surg 2011;98: 918-24. http://dx.doi.org/10.1002/bjs.7462
114. Siim E, Dahlstrom K, Drzewiecki KT, Andersson AP. The effect of fibrin adhesive on postoperative wound secretion after lymph node dissection. Reg Cancer Treat 1994;1: 51-3.
115. Gilly FN, Carry PY, Brachet A, Curtil A, Burgard G, Buisson L, et al. [Efficacity of fibrin glue on lymphostasis during lymph node dissection. Prospective randomised study in 40 patients.] Annales de Chirurgie 1994;48: 194-6.
116. Furrer M, Inderbitzi R, Nachbur B. [Does administration of fibrin glue prevent development of lymphoceles after radical lymphadenectomy?] Chirurg 1993;64: 1044-9.
117. Di Monta G, Caracò C, Crispo A, Marone U, Mozzillo N. Collagen sealant patch to reduce lymphatic drainage after lymph node dissection. World J Surg Oncol 2012;10: 275. http://dx.doi.org/10.1186/1477-7819-10-275
118. Neuss H, Raue W, Koplin G, Schwenk W, Reetz C, Mall JW. A prospective randomized trial: the influence of intraoperative application of fibrin glue after radical inguinal/iliacal lymph node dissection on postoperative morbidity. Eur J Surg Oncol 2009;35: 884-9. http://dx.doi.org/10.1016/j.ejso.2008.09.016
119. Simonato A, Varca V, Esposito M, Venzano F, Carmignani G. The use of a surgical patch in the prevention of lymphoceles after extraperitoneal pelvic lymphadenectomy for prostate cancer: a randomized prospective pilot study. J Urol 2009;182: 2285-90. http://dx.doi.org/10.1016/ j.juro.2009.07.033
120. Mortenson MM, Xing Y, Weaver S, Lee JE, Gershenwald JE, Lucci A, et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311). World J Surg Oncol 2008;6: 63. http://dx.doi.org/10.1186/1477-7819-6-63
121. Scholz HS, Petru E, Benedicic C, Haas J, Tamussino K, Winter R. Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies. Gynecol Oncol 2002;84: 43-6. http://dx.doi.org/10.1006/gyno.2001.6462
122. Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Ueda S, Fujii T, et al. Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial. World J Surg 2003;27: 776-81. http://dx.doi.org/10.1007/s00268-003-6989-5
123. Nielsen BP, Willumsen H, Rashmussen OV. [The secretion inhibition effect of fibrin glue in mastectomy scars. A prospective, randomized, clinically controlled study.] Ugeskr Laeger 1985;147: 1995-6.
124. Droghetti A, Schiavini A, Muriana P, Folloni A, Picarone M, Bonadiman C, et al. A prospective randomized trial comparing completion technique of fissures for lobectomy: stapler versus precision dissection and sealant. J Thorac Cardiovasc Surg 2008;136: 383-91. http://dx.doi.org/10.1016/j.jtcvs.2008.04.014
125. Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A, Smolle-Jüttner F. Efficiency of fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial. Eur J Cardiothorac Surg 2007;31: 198-202. http://dx.doi.org/10.1016/j.ejcts.2006.11.033
126. Moser C, Opitz I, Zhai W, Rousson V, Russi EW, Weder W, et al. Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. J Thorac Cardiovasc Surg 2008;136: 843-9. http://dx.doi.org/10.1016/j.jtcvs.2008.02.079
127. Rena O, Papalia E, Mineo TC, Massera F, Pirondini E, Turello D, et al. Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment. Interact Cardiovasc Thorac Surg 2009;9: 973-7. http://dx.doi.org/10.1510/icvts.2009.202770
128. Fabian T, Federico JA, Ponn RB. Fibrin glue in pulmonary resection: a prospective, randomized, blinded study. Ann Thorac Surg 2003;75: 1587-92. http://dx.doi.org/10.1016/S0003-4975(02)04994-9
129. Lopez C, Facciolo F, Lequaglie C, Rendina EA, Saita S, Dell’Amore D, et al. Efficacy and safety of fibrin sealant patch in the treatment of air leakage in thoracic surgery. Minerva Chir 2013;68: 559-67.
130. Gonfiotti A, Santini PF, Jaus M, Janni A, Lococo A, De Massimi AR, et al. Safety and effectiveness of a new fibrin pleural air leak sealant: a multicenter, controlled, prospective, parallel-group, randomized clinical trial. Ann Thorac Surg 2011;92: 1217-25. http://dx.doi.org/10.1016/ j.athoracsur.2011.05.104
131. Belcher E, Dusmet M, Jordan S, Ladas G, Lim E, Goldstraw P. A prospective, randomized trial comparing BioGlue and Vivostat for the control of alveolar air leak. J Thorac Cardiovasc Surg 2010;140: 32-8. http://dx.doi.org/10.1016/j.jtcvs.2009.11.064
132. Mouritzen C, Drömer M, Keinecke HO. The effect of fibrin glueing to seal bronchial and alveolar leakages after pulmonary resections and decortications. Eur J Cardiothorac Surg 1993;7: 75-80. http://dx.doi.org/10.1016/1010-7940(93)90184-D
133. Belboul A, Dernevik L, Aljassim O, Skrbic B, Radberg G, Roberts D. The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy: a prospective randomised, blinded study. Eur J Cardiothorac Surg 2004;26: 1187-91. http://dx.doi.org/10.1016/j.ejcts.2004.08.009
134. Lang G, Csekeo A, Stamatis G, Lampl L, Hagman L, Marta GM, et al. Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy. Eur J Cardiothorac Surg 2004;25: 160-6. http://dx.doi.org/10.1016/j.ejcts.2003.11.018
135. Marta GM, Facciolo F, Ladegaard L, Dienemann H, Csekeo A, Rea F, et al. Efficacy and safety of TachoSil® versus standard treatment of air leakage after pulmonary lobectomy. Eur J Cardiothorac Surg 2010;38: 683-9. http://dx.doi.org/10.1016/j.ejcts.2010.03.061
136. Filosso PL, Ruffini E, Sandri A, Lausi PO, Giobbe R, Oliaro A. Efficacy and safety of human fibrinogen-thrombin patch (TachoSil®) in the treatment of postoperative air leakage in patients submitted to redo surgery for lung malignancies: a randomized trial. Interact Cardiovasc Thorac Surg 2013;16: 661-6. http://dx.doi.org/10.1093/icvts/ivs571
137. Czerny M, Fleck T, Salat A, Zimpfer D, Klepetko W, Wolner E, et al. Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma. Ann Thorac Surg 2004;77: 1028-32. http://dx.doi.org/10.1016/j.athoracsur.2003.08.041
138. Kjaergard HK, Trumbull HR. Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 1998;66: 482-6. http://dx.doi.org/10.1016/ S0003-4975(98)00470-6
139. Kjaergard HK, Trumbull HR. Bleeding from the sternal marrow can be stopped using Vivostat patient-derived fibrin sealant. Ann Thorac Surg 2000;69: 1173-5. http://dx.doi.org/10.1016/ S0003-4975(99)01560-X
140. Maisano F, Kjaergård HK, Bauernschmitt R, Pavie A, Rábago G, Laskar M, et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg 2009;36: 708-14. http://dx.doi.org/10.1016/j.ejcts.2009.04.057
141. Lassen MR, Solgaard S, Kjersgaard AG, Olsen C, Lind B, Mittet K, et al. A pilot study of the effects of Vivostat patient-derived fibrin sealant in reducing blood loss in primary hip arthroplasty. Clin Appl Thromb Hemost 2006;12: 352-7. http://dx.doi.org/10.1177/1076029606291406
142. Heyse TJ, Haas SB, Drinkwater D, Lyman S, Kim HJ, Kahn BA, et al. Intraarticular fibrinogen does not reduce blood loss in TKA: a randomized clinical trial. Clin Orthop Relat Res 2014;472: 272-6. http://dx.doi.org/10.1007/s11999-013-3036-1
143. Aguilera X, Martinez-Zapata MJ, Bosch A, Urrutia G, Gonzalez JC, Jordan M, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am 2013;95: 2001-7. http://dx.doi.org/10.2106/JBJS.L.01182
144. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001;83-A: 1503-5. http://dx.doi.org/10.2106/00004623-200110000-00007
145. Kluba T, Fiedler K, Kunze B, Ipach I, Suckel A. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch Orthop Trauma Surg 2012;132: 1147-52. http://dx.doi.org/10.1007/s00402-012-1519-2
146. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 2012;19: 295-8. http://dx.doi.org/10.1016/j.knee.2011.06.004
147. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 2007;89: 306-9. http://dx.doi.org/10.1302/0301-620X.89B3.17565
148. Sabatini L, Trecci A, Imarisio D, Uslenghi MD, Bianco G, Scagnelli R. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 2012;13: 145-51. http://dx.doi.org/10.1007/s10195-012-0198-7
149. Randelli F, D’Anchise R, Ragone V, Serrao L, Cabitza P, Randelli P. Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. J Arthroplasty 2014;29: 1516-20. http://dx.doi.org/10.1016/j.arth.2014.02.024
150. Skovgaard C, Holm B, Troelsen A, Lunn TH, Gaarn-Larsen L, Kehlet H, et al. No effect of fibrin sealant on drain output or functional recovery following simultaneous bilateral total knee arthroplasty: a randomized, double-blind, placebo-controlled study. Acta Orthop 2013;84: 153-8. http://dx.doi.org/10.3109/17453674.2013.769082
151. Choufani C, Barbier O, Bajard X, Ollat D, Versier G. [Medical and economic impact of a haemostatic sealant on the rate of transfusion after total knee arthroplasty.] Transfus Clin Biol 2015;22: 22-9. http://dx.doi.org/10.1016/j.tracli.2015.01.001
152. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T. Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 2006;14: 117-21. http://dx.doi.org/10.1177/230949900601400202
153. Wang GJ, Goldthwaite CA, Burks S, Crawford R, Spotnitz WD, Orthopaedic Investigators Group. Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 2003;13: 399-411. http://dx.doi.org/10.1615/JLongTermEffMedImplants.v13.i5.50
154. Falez F, Meo A, Panegrossi G, Favetti F, La Cava F, Casella F. Blood loss reduction in cementless total hip replacement with fibrin spray or bipolar sealer: a randomised controlled trial on ninety five patients. Int Orthop 2013;37: 1213-17. http://dx.doi.org/10.1007/s00264-013-1903-8
155. Antuña S, Barco R, Martínez Diez JM, Sánchez Márquez JM. Platelet-rich fibrin in arthroscopic repair of massive rotator cuff tears: a prospective randomized pilot clinical trial. Acta Orthop Belg 2013;79: 25-30.
156. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. Acta Orthop 2011;82: 660-3. http://dx.doi.org/10.3109/17453674.2011.623568
157. Kucukerdonmez C, Karalezli A, Akova YA, Borazan M. Amniotic membrane transplantation using fibrin glue in pterygium surgery: a comparative randomised clinical trial. Eye 2010;24: 558-66. http://dx.doi.org/10.1038/eye.2009.136
158. Yüksel B, Unsal SK, Onat S. Comparison of fibrin glue and suture technique in pterygium surgery performed with limbal autograft. Int J Ophthalmol 2010;3: 316-20.
159. Bahar I, Weinberger D, Dan G, Avisar R. Pterygium surgery: fibrin glue versus Vicryl sutures for conjunctival closure. Cornea 2006;25: 1168-72. http://dx.doi.org/10.1097/01.ico.0000240087.32922.ee
160. Hall RC, Logan AJ, Wells AP. Comparison of fibrin glue with sutures for pterygium excision surgery with conjunctival autografts. Clin Exp Ophthalmol 2009;37: 584-9. http://dx.doi.org/10.1111/j.1442-9071.2009.02105.x
161. Karalezli A, Kucukerdonmez C, Akova YA, Altan-Yaycioglu R, Borazan M. Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: a prospective comparative study. Br J Ophthalmol 2008;92: 1206-10. http://dx.doi.org/10.1136/bjo.2008.139600
162. Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand 2005;83: 298-301. http://dx.doi.org/10.1111/ j.1600-0420.2005.00465.x
163. Sati A, Shankar S, Jha A, Kalra D, Mishra S, Gurunadh VS. Comparison of efficacy of three surgical methods of conjunctival autograft fixation in the treatment of pterygium. Int Ophthalmol 2014;34: 1233-9. http://dx.doi.org/10.1007/s10792-014-0013-y
164. Sharma A, Kaur R, Kumar S, Gupta P, Pandav S, Patnaik B, et al. Fibrin glue versus N-butyl-2- cyanoacrylate in corneal perforations. Ophthalmology 2003;110: 291-8. http://dx.doi.org/10.1016/ S0161-6420(02)01558-0
165. Ratnalingam V, Eu AL, Ng GL, Taharin R, John E. Fibrin adhesive is better than sutures in pterygium surgery. Cornea 2010;29: 485-9. http://dx.doi.org/10.1097/ICO.0b013e3181c29696
166. Rubin MR, Dantas PE, Nishiwaki-Dantas MC, Felberg S. [Efficacy of fibrin tissue adhesive in the attachment of autogenous conjuntival graft on primary pterygium surgery.] Arq Bras Oftalmol 2011;74: 123-6. http://dx.doi.org/10.1590/S0004-27492011000200011
167. Srinivasan S, Dollin M, McAllum P, Berger Y, Rootman DS, Slomovic AR. Fibrin glue versus sutures for attaching the conjunctival autograft in pterygium surgery: a prospective observer masked clinical trial. Br J Ophthalmol 2009;93: 215-18. http://dx.doi.org/10.1136/bjo.2008.145516
168. Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology 2005;112: 667-71. http://dx.doi.org/10.1016/j.ophtha.2004.08.028
169. Bahar I, Weinberger D, Gaton DD, Avisar R. Fibrin glue versus vicryl sutures for primary conjunctival closure in pterygium surgery: long-term results. Curr Eye Res 2007;32: 399-405. http://dx.doi.org/10.1080/02713680701294723
170. Mellin KB, Kondler R. [Management of conjunctival wounds with suture or fibrin glue following intraocular lens implantation - a comparative study.] Fortschr Ophthalmol 1989;86: 129-31.
171. Malik VK, Kumar S. Use of fibrin glue in the management of recurrent pterygium by conjunctival autograft. Saudi Med J 2010;31: 1326-30.
172. Lau H. Fibrin sealant versus mechanical stapling for mesh fixation during endoscopic extraperitoneal inguinal hernioplasty: a randomized prospective trial. Ann Surg 2005;242: 670-5. http://dx.doi.org/10.1097/01.sla.0000186440.02977.de
173. Boldo E. Pain after laparascopic bilateral hernioplasty: early results of a prospective randomized double-blind study comparing fibrin versus staples. Surg Endosc 2008;22: 1206-9. http://dx.doi.org/10.1007/s00464-007-9587-z
174. Bracale U, Rovani M, Picardo A, Merola G, Pignata G, Sodo M, et al. Beneficial effects of fibrin glue (Quixil) versus Lichtenstein conventional technique in inguinal hernia repair: a randomized clinical trial. Hernia 2014;18: 185-92. http://dx.doi.org/10.1007/s10029-012-1020-4
175. Cambal M, Zonca P, Hrbaty B. Comparison of self-gripping mesh with mesh fixation with fibrin-glue in laparoscopic hernia repair (TAPP). Bratisl Lek Listy 2012;113: 103-7. http://dx.doi.org/10.4149/bll_2012_024
176. Campanelli G, Pascual MH, Hoeferlin A, Rosenberg J, Champault G, Kingsnorth A, et al. Randomized, controlled, blinded trial of Tisseel/Tissucol for mesh fixation in patients undergoing Lichtenstein technique for primary inguinal hernia repair: results of the TIMELI trial. Ann Surg 2012;255: 650-7. http://dx.doi.org/10.1097/SLA.0b013e31824b32bf
177. Canonico S, Sciaudone G, Pacifico F, Santoriello A. Inguinal hernia repair in patients with coagulation problems: prevention of postoperative bleeding with human fibrin glue. Surgery 1999;125: 315-17. http://dx.doi.org/10.1016/S0039-6060(99)70242-4
178. Chan MS, Teoh AY, Chan KW, Tang YC, Ng EK, Leong HT. Randomized double-blinded prospective trial of fibrin sealant spray versus mechanical stapling in laparoscopic total extraperitoneal hernioplasty. Ann Surg 2014;259: 432-7. [Erratum published in Ann Surg 2014;260: 408.] http://dx.doi.org/10.1097/SLA.0b013e3182a6c513
179. Lionetti R, Neola B, Dilillo S, Bruzzese D, Ferulano GP. Sutureless hernioplasty with light-weight mesh and fibrin glue versus Lichtenstein procedure: a comparison of outcomes focusing on chronic postoperative pain. Hernia 2012;16: 127-31. http://dx.doi.org/10.1007/s10029-011-0869-y
180. Lovisetto F, Zonta S, Rota E, Mazzilli M, Bardone M, Bottero L, et al. Use of human fibrin glue (Tissucol) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty: a prospective, randomized study. Ann Surg 2007;245: 222-31. http://dx.doi.org/10.1097/01.sla.0000245832.59478.c6
181. Tolver MA, Rosenberg J, Juul P, Bisgaard T. Randomized clinical trial of fibrin glue versus tacked fixation in laparoscopic groin hernia repair. Surg Endosc 2013;27: 2727-33. http://dx.doi.org/10.1007/s00464-012-2766-6
182. Wong JU, Leung TH, Huang CC, Huang CS. Comparing chronic pain between fibrin sealant and suture fixation for bilayer polypropylene mesh inguinal hernioplasty: a randomized clinical trial. Am J Surg 2011;202: 34-8. http://dx.doi.org/10.1016/j.amjsurg.2010.05.004
183. Eriksen JR, Bisgaard T, Assaadzadeh S, Jorgensen LN, Rosenberg J. Fibrin sealant for mesh fixation in laparoscopic umbilical hernia repair: 1-year results of a randomized controlled double-blinded study. Hernia 2013;174: 511-14. http://dx.doi.org/10.1007/s10029-013-1101-z
184. Damiano G, Gioviale MC, Palumbo VD, Spinelli G, Buscemi S, Ficarella S, et al. Human fibrin glue sealing versus suture polypropylene fixation in Lichtenstein inguinal herniorrhaphy: a prospective observational study. Chirurgia 2014;109: 660-3.
185. Olmi S, Scaini A, Erba L, Guaglio M, Croce E. Quantification of pain in laparoscopic transabdominal preperitoneal (TAPP) inguinal hernioplasty identifies marked differences between prosthesis fixation systems. Surgery 2007;142: 40-6. http://dx.doi.org/10.1016/j.surg.2007.02.013
186. Pryor SG, Sykes J, Tollefson TT. Efficacy of fibrin sealant (human) (Evicel) in rhinoplasty: a prospective, randomized, single-blind trial of the use of fibrin sealant in lateral osteotomy. Arch Facial Plast Surg 2008;10: 339-44. http://dx.doi.org/10.1001/archfaci.10.5.339
187. Prado A, Andrades P, Danilla S, Benitez S, Wisnia P. Use of aerosolized bovine-prepared fibrin glue for skin fixation after primary open rhinoplasty: a prospective randomized and controlled trial. Aesthetic Plast Surg 2006;30: 568-73. http://dx.doi.org/10.1007/s00266-006-0020-0
188. Vaiman M, Eviatar E, Segal S. The use of fibrin glue as hemostatic in endonasal operations: a prospective, randomized study. Rhinology 2002;40: 185-8.
189. Vaiman M, Sarfaty S, Shlamkovich N, Segal S, Eviatar E. Fibrin sealant: alternative to nasal packing in endonasal operations. A prospective randomized study. Isr Med Assoc J 2005;7: 571-4.
190. Yu MS, Kang SH, Kim BH, Lim DJ. Effect of aerosolized fibrin sealant on hemostasis and wound healing after endoscopic sinus surgery: a prospective randomized study. Am J Rhinol Allergy 2014;28: 335-40. http://dx.doi.org/10.2500/ajra.2014.28.4047
191. Vaiman M, Eviatar E, Shlamkovich N, Segal S. Use of fibrin glue as a hemostatic in endoscopic sinus surgery. Ann Otol Rhinol Laryngol 2005;114: 237-41. http://dx.doi.org/10.1177/000348940511400313
192. Vaiman M, Krakovski D, Gavriel H. Fibrin sealant reduces pain after tonsillectomy: prospective randomized study. Ann Otol Rhinol Laryngol 2006;115: 483-9. http://dx.doi.org/10.1177/000348940611500701
193. Jackson MR, Gillespie DL, Longenecker EG, Goff JM, Fiala LA, O’Donnell SD, et al. Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial. J Vasc Surg 1999;30: 461-6. http://dx.doi.org/10.1016/S0741-5214(99)70073-X
194. Bajardi G, Pecoraro F, Mirabella D. Efficacy of TachoSil patches in controlling Dacron suture-hole bleeding after abdominal aortic aneurysm open repair. J Cardiothorac Surg 2009;4: 60. http://dx.doi.org/10.1186/1749-8090-4-60
195. Schenk WG, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003;237: 871-6. http://dx.doi.org/10.1097/01.SLA.0000071565.02994.DA
196. Schenk WG, Goldthwaite CA Jr, Burks S, Spotnitz WD. Fibrin sealant facilitates hemostasis in arteriovenous polytetrafluoroethylene grafts for renal dialysis access. Am Surg 2002;68: 728-32.
197. Saha SP, Muluk S, Schenk IW, Dennis JW, Ploder B, Grigorian A, et al. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts. J Vasc Surg 2012;56: 134-41. http://dx.doi.org/10.1016/j.jvs.2012.01.009
198. Chalmers RT, Darling Iii RC, Wingard JT, Chetter I, Cutler B, Kern JA, et al. Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures. Br J Surg 2010;97: 1784-9. http://dx.doi.org/10.1002/bjs.7235
199. Taylor LM Jr, Mueller-Velten G, Koslow A, Hunter G, Naslund T, Kline R. Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needlehole bleeding from polytetrafluoroethylene femoral artery grafts. J Vasc Surg 2003;38: 766-71. http://dx.doi.org/10.1016/S0741-5214(03)00474-9
200. Joseph T, Adeosun A, Paes T, Bahal V. Randomised controlled trial to evaluate the efficacy of TachoComb H patches in controlling PTFE suture-hole bleeding. Eur J Vasc Endovasc Surg 2004;27: 549-52. http://dx.doi.org/10.1016/j.ejvs.2004.01.018
201. Milne AA, Murphy WG, Reading SJ, Ruckley CV. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomised trial. Eur J Vasc Endovasc Surg 1995;10: 91-4. http://dx.doi.org/10.1016/S1078-5884(05)80203-5
202. Sintler MP, Mahmood A, Smith SRG, Simms MH, Vohra RK. Randomized trial comparing quixil surgical sealant with kaltostat hemostatic dressing to control suture line bleeding after carotid endarterectomy with ePTFE patch reconstruction. World J Surg 2005;29: 1259-62. http://dx.doi.org/10.1007/s00268-005-7863-4
203. Milne AA, Murphy WG, Reading SJ, Ruckley CV. A randomised trial of fibrin sealant in peripheral vascular surgery. Vox Sang 1996;70: 210-12. http://dx.doi.org/10.1111/ j.1423-0410.1996.tb01328.x
204. Saha SP, Muluk S, Schenk W, Burks SG, Grigorian A, Ploder B, et al. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery. Ann Vasc Surg 2011;25: 813-22. http://dx.doi.org/10.1016/j.avsg.2010.12.016
205. Czerny M, Verrel F, Weber H, Müller N, Kircheis L, Lang W, et al. Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg 2000;41: 553-7.
206. Altinli E, Koksal N, Onur E, Celik A, Sumer A. Impact of fibrin sealant on Limberg flap technique: results of a randomized controlled trial. Tech Coloproctol 2007;11: 22-5. http://dx.doi.org/10.1007/s10151-007-0320-7
207. Drake DB, Wong LG. Hemostatic effect of Vivostat patient-derived fibrin sealant on split-thickness skin graft donor sites. Ann Plast Surg 2003;50: 367-72. http://dx.doi.org/10.1097/01.SAP.0000041484.22953.6D
208. Vanscheidt W, Ukat A, Horak V, Bruning H, Hunyadi J, Pavlicek R, et al. Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant: a multinational randomized controlled clinical trial. Wound Repair Regen 2007;15: 308-15. http://dx.doi.org/10.1111/ j.1524-475X.2007.00231.x
209. Danielsen P, Jørgensen B, Karlsmark T, Jorgensen LN, Agren MS. Effect of topical autologous platelet-rich fibrin versus no intervention on epithelialization of donor sites and meshed splitthickness skin autografts: a randomized clinical trial. Plast Reconstr Surg 2008;122: 1431-40. http://dx.doi.org/10.1097/PRS.0b013e318188202c
210. Erba P, di Summa PG, Wettstein R, Raffoul W, Kalbermatten DF. Fibrin sealant for fasciocutaneous flaps. J Reconstr Microsurg 2010;26: 213-17. http://dx.doi.org/10.1055/s-0030-1247716
211. Healy C, Greig AV, Murphy AD, Powell C, Pinder RJ, Saour S, et al. Prospective randomized controlled trial: fibrin sealant reduces split skin graft donor-site pain. Plast Reconstr Surg 2013;132: 139e-46e. http://dx.doi.org/10.1097/PRS.0b013e318299c6f4
212. Sözen S, Emir S, Güzel K, Ozdemir CS. Are postoperative drains necessary with the Karydakis flap for treatment of pilonidal sinus? (Can fibrin glue be replaced to drains?) A prospective randomized trial. Ir J Med Sci 2011;180: 479-82. http://dx.doi.org/10.1007/s11845-010-0549-4
213. Bercial ME, Sabino Neto M, Calil JA, Rossetto LA, Ferreira LM. Suction drains, quilting sutures, and fibrin sealant in the prevention of seroma formation in abdominoplasty: which is the best strategy? Aesthetic Plast Surg 2012;36: 370-3. http://dx.doi.org/10.1007/s00266-011-9807-8
214. Mabrouk AA, Helal HA, Al Mekkawy SF, Mahmoud NA, Abdel-Salam AM. Fibrin sealant and lipoabdominoplasty in obese grade 1 and 2 patients. Arch Plast Surg 2013;40: 621-6. http://dx.doi.org/10.5999/aps.2013.40.5.621
215. Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty GB. Can fibrin sealant be used to prevent postoperative drainage? A prospective randomized double blind trial. Eur J Plast Surg 2002;24: 387-90. http://dx.doi.org/10.1007/s00238-001-0317-9
216. Ellis CN, Clark S. Fibrin glue as an adjunct to flap repair of anal fistulas: a randomized, controlled study. Dis Colon Rectum 2006;49: 1736-40. http://dx.doi.org/10.1007/s10350-006-0718-8
217. Altomare DF, Greco VJ, Tricomi N, Arcana F, Mancini S, Rinaldi M, et al. Seton or glue for trans-sphincteric anal fistulae: a prospective randomized crossover clinical trial. Colorectal Dis 2011;13: 82-6. http://dx.doi.org/10.1111/j.1463-1318.2009.02056.x
218. Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum 2002;45: 1608-15. http://dx.doi.org/10.1007/s10350-004-7247-0
219. Hammond TM, Porrett TR, Scott SM, Williams NS, Lunniss PJ. Management of idiopathic anal fistula using cross-linked collagen: a prospective phase 1 study. Colorectal Dis 2011;13: 94-104. http://dx.doi.org/10.1111/j.1463-1318.2009.02087.x
220. van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG. Staged mucosal advancement flap versus staged fibrin sealant in the treatment of complex perianal fistulas. Gastroenterol Res Pract 2011;2011: 186350. http://dx.doi.org/10.1155/2011/186350
221. Siemer S, Lahme S, Altziebler S, Machtens S, Strohmaier W, Wechsel HW, et al. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. Eur Urol 2007;52: 1156-63. http://dx.doi.org/10.1016/ j.eururo.2007.04.027
222. Cormio L, Perrone A, Di Fino G, Ruocco N, De Siati M, de la Rosette J, et al. TachoSil® sealed tubeless percutaneous nephrolithotomy to reduce urine leakage and bleeding: outcome of a randomized controlled study. J Urol 2012;188: 145-50. http://dx.doi.org/10.1016/j.juro.2012.03.011
223. Luke M, Kvist E, Andersen F, Hjortrup A. Reduction of post-operative bleeding after transurethral resection of the prostate by local instillation of fibrin adhesive (Beriplast). Br J Urol 1986;58: 672-5. http://dx.doi.org/10.1111/j.1464-410X.1986.tb05910.x
224. Schultz A, Christiansen LA. Fibrin adhesive sealing of ureter after ureteral stone surgery. A controlled clinical trial. Eur Urol 1985;11: 267-8.
225. Uwiera TC, Uwiera RR, Seikaly H, Harris JR. Tisseel and its effects on wound drainage postthyroidectomy: prospective, randomized, blinded, controlled study. J Otolaryngol 2005;34: 374-8. http://dx.doi.org/10.2310/7070.2005.34603
226. Marchac D, Greensmith AL. Early postoperative efficacy of fibrin glue in face lifts: a prospective randomized trial. Plast Reconstr Surg 2005;115: 911-16. http://dx.doi.org/10.1097/01.PRS.0000153219.32665.D5
227. Lee S, Pham AM, Pryor SG, Tollefson T, Sykes JM. Efficacy of Crosseal fibrin sealant (human) in rhytidectomy. Arch Facial Plast Surg 2009;11: 29-33. http://dx.doi.org/10.1001/archfacial.2008.511
228. Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty BG. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg 2001;108: 2101-5, discussion 2106-7. http://dx.doi.org/10.1097/00006534-200112000-00044
229. Carter G, Goss A, Lloyd J, Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg 2003;61: 1432-5. http://dx.doi.org/10.1016/j.joms.2003.01.001
230. Maharaj M, Diamond C, Williams D, Seikaly H, Harris J. Tisseel to reduce postparotidectomy wound drainage: randomized, prospective, controlled trial. J Otolaryngol 2006;35: 36-9. http://dx.doi.org/10.2310/7070.2005.4032
231. Hester TR Jr, Shire JR, Nguyen DB, Gerut ZE, Chen AH, Diamond J, et al. Randomized, controlled, phase 3 study to evaluate the safety and efficacy of fibrin sealant VH S/D 4 s-apr (Artiss) to improve tissue adherence in subjects undergoing rhytidectomy. Aesthet Surg J 2013;33: 487-96. http://dx.doi.org/10.1177/1090820X13479969
232. Diamond MP, Korell M, Martinez S, Kurman E, Kamar M, Freeman M, et al. A prospective, controlled, randomized, multicenter, exploratory pilot study evaluating the safety and potential trends in efficacy of Adhexil. Fertil Steril 2011;95: 1086-90. http://dx.doi.org/10.1016/ j.fertnstert.2010.11.024
233. Maggiore ULR, Alessandri F, Ferrero S. Tachosil application after laparoscopic myomectomy: a prospective randomized trial. Ital J Gynaecol Obstet 2011;23: 147-54.
234. Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kinoshita K. Adhesion-prevention effects of fibrin sealants after laparoscopic myomectomy as determined by second-look laparoscopy: a prospective, randomized, controlled study. J Reprod Med 2005;50: 571-7.
235. Safan A, Shaker H, Abdelaal A, Mourad MS, Albaz M. Fibrin glue versus martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn 2009;28: 438-41. http://dx.doi.org/10.1002/ nau.20754
236. Nakamura H, Matsuyama Y, Yoshihara H, Sakai Y, Katayama Y, Nakashima S, et al. The effect of autologous fibrin tissue adhesive on postoperative cerebrospinal fluid leak in spinal cord surgery: a randomized controlled trial. Spine 2005;30: 347-51. http://dx.doi.org/10.1097/01.brs.0000167820.54413.8e
237. Hutter G, von Felten S, Sailer MH, Schulz M, Mariani L. Risk factors for postoperative CSF leakage after elective craniotomy and the efficacy of fleece-bound tissue sealing against dural suturing alone: a randomized controlled trial. J Neurosurg 2014;121: 735-44. http://dx.doi.org/10.3171/2014.6.JNS131917
238. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 2003;35: 439-44. http://dx.doi.org/10.1159/000072229
239. Bochicchio GV, Gupta N, Porte RJ, Renkens KL, Pattyn P, Topal B, et al. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis. J Am Coll Surg 2015;220: 70-81. http://dx.doi.org/10.1016/j.jamcollsurg.2014.09.019
240. Verhoef C, Singla N, Moneta G, Muir W, Rijken A, Lockstadt H, et al. Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials. J Surg Res 2015;194: 679-87. http://dx.doi.org/10.1016/j.jss.2014.12.011
241. Fischer CP, Bochicchio G, Shen J, Patel B, Batiller J, Hart JC. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. J Am Coll Surg 2013;217: 385-93. http://dx.doi.org/10.1016/j.jamcollsurg.2013.02.036
242. Cagatay HH, Gokce G, Ekinci M, Koban Y, Daraman O, Ceylan E. Long-term comparison of fibrin tissue glue and vicryl suture in conjunctival autografting for pterygium surgery. Postgrad Med 2014;126: 97-103. http://dx.doi.org/10.3810/pgm.2014.01.2729
243. Jiang J, Yang Y, Zhang M, Fu X, Bao X, Yao K. Comparison of fibrin sealant and sutures for conjunctival autograft fixation in pterygium surgery: one-year follow-up. Ophthalmologica 2008;222: 105-11. http://dx.doi.org/10.1159/000112627
244. Choi SH, Lee EK, Nam KY, Kim JY. Fibrin glue-assisted conjunctival closure in pars plana vitrectomy where conjunctival closure with a suture would be difficult. Retina 2010;30: 688-91. http://dx.doi.org/10.1097/IAE.0b013e3181cdf398
245. Efthimiou E, Al-Sabah S, Sampalis JS, Christou NV. Fibrin sealant associated with increased body temperature and leukocytosis after laparoscopic gastric bypass. Surg Obes Relat Dis 2010;6: 46-9. http://dx.doi.org/10.1016/j.soard.2009.03.002
246. Ibele AR, Bendewald FP, Mattar SG, McKenna DT. Incidence of gastrojejunostomy stricture in laparoscopic Roux-en-Y gastric bypass using an autologous fibrin sealant. Obes Surg 2014;24: 1052-6. http://dx.doi.org/10.1007/s11695-014-1204-3
247. Nanashima A, Tobinaga S, Kunizaki M, Nonaka T, Takeshita H, Hidaka S, et al. Does fibrin glue prevent biliary and pancreatic fistula after surgical resection? Hepatogastroenterology 2012;59: 1544-7.
248. Marchac D, Sándor G. Face lifts and sprayed fibrin glue: an outcome analysis of 200 patients. Br J Plast Surg 1994;47: 306-9. http://dx.doi.org/10.1016/0007-1226(94)90087-6
249. Sakic A, Chevtchik O, Kilo J, Schistek R, Mueller LC, Ulmer H, et al. Simple adaptations of surgical technique to critically reduce the risk of postoperative sternal complications in patients receiving bilateral internal thoracic arteries. Interact Cardiovasc Thorac Surg 2013;17: 378-82. http://dx.doi.org/10.1093/icvts/ivt089
250. Moench C, Bechstein WO, Hermanutz V, Hoexter G, Knaebel H. Comparison of the collagen haemostat Sangustop versus a carrier-bound fibrin sealant during liver resection; ESSCALIVERStudy. Trials 2010;11. http://dx.doi.org/10.1186/1745-6215-11-109
251. Vaxman F, Kolbe R, Stricher F, Boullenois JN, Volkmar P, Gros D, et al. Fibrin glue does not reduce lymphorrhoea after axillary lymph node dissection. Annales de Chirurgie 1995;49: 411-16.
252. Lim-Bon-Siong R, Valluri S, Gordon M, Pepose J. Efficacy and safety of the ProTek (Vifilcon A) therapeutic soft contact lens after photorefractive keratectomy. Am J Ophthalmol 1998;125: 169-76. http://dx.doi.org/10.1016/S0002-9394(99)80087-7
253. Wong DL, Hockenberry-Eaton M, Wilson D, Winkelstein ML, Schwartz P. Wong’s Essentials of Pediatric Nursing. 6th edn. St Louis, MO; Mosby; 2001.
254. MHRA. Sprayable Fibrin Sealants (Evicel, Tisseel and Artiss): Updated Guidance. 2013. URL: www. gov.uk/drug-safety-update/sprayable-fibrin-sealants-evicel-tisseel-and-artiss-updated-guidance (accessed 11 November 2015)s.
255. EMA. Fibrinogen-Containing Solutions for Sealant Authorised For Administration by Spray Application. 2013. URL: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/ Fibrinogen-containing_solutions_for_sealant_authorised_for_administration_by_spray_application/ human_referral_000332.jsp&mid=WC0b01ac05805c516f (accessed 11 November 2015).
256. FDA. Risk of Life-Threatening Air or Gas Embolism with the Use of Spray Devices Employing Pressure Regulator to Administer Fibrin Sealants (Baxter Healthcare Corporation). 2009. URL: www.fda.gov/biologicsbloodvaccines/safetyavailability/ucm209778.htm (accessed 11 November 2015).
257. FDA. Pediatric Safety and Utilization Review for the Pediatric Advisory Committee (PAC) Meeting. URL: www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/ pediatricadvisorycommittee/ucm386895.doc (accessed 11 November 2015).
258. FDA. MDR Analysis of Tisseel Fibrin Sealant Delivery Systems. 2014. URL: www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/pediatricadvisorycommittee/ ucm388149.pdf (accessed 11 November 2015).
259. Olmi S, Scaini A, Erba L, Bertolini A, Croce E. Laparoscopic repair of inguinal hernias using an intraperitoneal onlay mesh technique and a Parietex composite mesh fixed with fibrin glue (Tissucol). Personal technique and preliminary results. Surg Endosc 2007;21: 1961-4. http://dx.doi.org/10.1007/s00464-007-9355-0
260. Eriksen JR, Bisgaard T, Assaadzadeh S, Nannestad Jorgensen L, Rosenberg J. Randomized clinical trial of fibrin sealant versus titanium tacks for mesh fixation in laparoscopic umbilical hernia repair. Br J Surg 2011;98: 1537-45. http://dx.doi.org/10.1002/bjs.7646
261. Shiono N, Koyama N, Watanabe Y, Tokuhiro K, Suzuki N, Fujii T. Application of cryoprecipitate as a hematostatic glue. J Cardiovasc Surg 1998;39: 609-12.